Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients
Journal
International journal of antimicrobial agents
Journal Volume
59
Journal Issue
1
Date Issued
2022-01
Author(s)
Chen, Chia-Hung
Chen, Wei-Chih
Wang, Yao-Tung
Lai, Chih-Cheng
Fu, Pin-Kuei
Kuo, Li-Kuo
Chen, Chin-Ming
Fang, Wen-Feng
Tu, Chih-Yen
Abstract
Both cefoperazone-sulbactam (CFP-SUL) and piperacillin-tazobactam (PIP-TAZ) are β-lactam/β-lactamase inhibitor antibiotics and have a similar antimicrobial spectrum. However, comparative clinical efficacy and safety of CFP-SUL and PIP-TAZ for the treatment of pneumonia remain largely unknown, especially in elderly patients.
Subjects
Adverse drug event; Cefoperazone-sulbactam; Outcome; Piperacillin-tazobactam; Pneumonia
SDGs
Publisher
ELSEVIER
Type
journal article